<?xml version="1.0" encoding="UTF-8"?>
<p>Unquestionably, much of the pathogenesis and optimal therapy of SARS-CoV-2 remains unknown, but we strongly believe that it is critically important that, when faced with uncertainty, clinicians stick to standards of care that are proven and robust. The SARS-CoV-2 pandemic is an opportunity to learn how to treat patients and test therapies at the same time (
 <xref rid="bib13" ref-type="bibr">13</xref>). Trials of experimental therapies are certainly justified, but only in properly conducted randomized controlled trials where their risks and benefits can be accurately assessed, and certainly not in untried combinations which greatly increase the risk of harm.
</p>
